Analysis of Defined Daily Dose (DDD) and antibiotic problems in Intensive Care Unit (ICU) patients

Yulistiani Yulistiani1,2, Hargus Haraudi Barkah2, Febriansyah Nur Utomo2

  • 1Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.

Insights

Antimicrobial resistance in ICUs necessitates evaluating antibiotic use with Defined Daily Doses (DDD) and Drug Related Problems (DRP) analysis to improve Antimicrobial Stewardship (AMS). High ceftriaxone use and DRPs highlight the need for better AMS programs.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacoeconomics

Background:

  • Antimicrobial resistance (AMR) in Intensive Care Units (ICUs) presents a major hurdle for effective infection control.
  • Quantitative assessment of antibiotic consumption via Defined Daily Dose (DDD) and Drug Related Problems (DRP) analysis is crucial for Antimicrobial Stewardship (AMS) programs.

Purpose of the Study:

  • To analyze the quantitative antibiotic use in ICU patients using the DDD method.
  • To identify Drug Related Problems (DRPs) in ICU patients to support AMS programs.

Main Methods:

  • Retrospective cross-sectional study of ICU patient medical records (July-December 2022).
  • Antibiotic consumption calculated using DDD per 100 patient-days (WHO standards).
  • DRPs identified using Cipolle and Pharmaceutical Care Network Europe (PCNE) v9.1 classifications.

Main Results:

  • Total antibiotic consumption was 91.54 DDD/100 patient-days; ceftriaxone was highest at 31.57 DDD/100 patient-days.
  • Pneumonia (40%) and sepsis (25%) were predominant conditions.
  • Most frequent DRPs included unnecessary drug therapy (20%) and suboptimal therapeutic effects (23%), often due to inappropriate indications or guideline deviations.

Conclusions:

  • High antibiotic use, dominated by ceftriaxone, and frequent DRPs in the ICU underscore the need for enhanced AMS.
  • Optimizing antibiotic use requires interdisciplinary collaboration, regular audits, and adherence to clinical guidelines to mitigate AMR risks.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
231
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
220
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
227
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
212
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
305
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.3K